Sonic Hedgehog is a determinant of γδ T-Cell differentiation in the Thymus by Mengrelis, Konstantinos et al.
Middlesex University Research Repository
An open access repository of
Middlesex University research
http://eprints.mdx.ac.uk
Mengrelis, Konstantinos, Lau, Ching-In, Rowell, Jasmine, Solanki, Anisha, Norris, Sonia, Ross,
Susan, Ono, Masahiro, Outram, Susan and Crompton, Tessa (2019) Sonic Hedgehog Is a
determinant of T-Cell differentiation in the Thymus. Frontiers in Immunology, 10 . p. 1629.
ISSN 1664-3224
Published version (with publisher’s formatting)
This version is available at: http://eprints.mdx.ac.uk/27274/
Copyright:
Middlesex University Research Repository makes the University’s research available electronically.
Copyright and moral rights to this work are retained by the author and/or other copyright owners
unless otherwise stated. The work is supplied on the understanding that any use for commercial gain
is strictly forbidden. A copy may be downloaded for personal, non-commercial, research or study
without prior permission and without charge.
Works, including theses and research projects, may not be reproduced in any format or medium, or
extensive quotations taken from them, or their content changed in any way, without first obtaining
permission in writing from the copyright holder(s). They may not be sold or exploited commercially in
any format or medium without the prior written permission of the copyright holder(s).
Full bibliographic details must be given when referring to, or quoting from full items including the
author’s name, the title of the work, publication details where relevant (place, publisher, date), pag-
ination, and for theses or dissertations the awarding institution, the degree type awarded, and the
date of the award.
If you believe that any material held in the repository infringes copyright law, please contact the
Repository Team at Middlesex University via the following email address:
eprints@mdx.ac.uk
The item will be removed from the repository while any claim is being investigated.
See also repository copyright: re-use policy: http://eprints.mdx.ac.uk/policies.html#copy
ORIGINAL RESEARCH
published: 19 July 2019
doi: 10.3389/fimmu.2019.01629
Frontiers in Immunology | www.frontiersin.org 1 July 2019 | Volume 10 | Article 1629
Edited by:
Loretta Tuosto,
Sapienza University of Rome, Italy
Reviewed by:
David L. Wiest,
Fox Chase Cancer Center,
United States
Terkild Brink Buus,
University of Copenhagen, Denmark
*Correspondence:
Tessa Crompton
t.crompton@ucl.ac.uk
†These authors have contributed
equally to this work as joint first
authors
Specialty section:
This article was submitted to
T Cell Biology,
a section of the journal
Frontiers in Immunology
Received: 22 January 2019
Accepted: 01 July 2019
Published: 19 July 2019
Citation:
Mengrelis K, Lau C-I, Rowell J,
Solanki A, Norris S, Ross S, Ono M,
Outram S and Crompton T (2019)
Sonic Hedgehog Is a Determinant of
γδ T-Cell Differentiation in the Thymus.
Front. Immunol. 10:1629.
doi: 10.3389/fimmu.2019.01629
Sonic Hedgehog Is a Determinant of
γδ T-Cell Differentiation in the
Thymus
Konstantinos Mengrelis 1†, Ching-In Lau 1†, Jasmine Rowell 1, Anisha Solanki 1,
Sonia Norris 1, Susan Ross 1, Masahiro Ono 2, Susan Outram 3 and Tessa Crompton 1*
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Here we investigate the function of Hedgehog (Hh) signaling in thymic γδ T-cell
maturation and subset differentiation. Analysis of Hh mutants showed that Hh signaling
promotes γδ T-cell development in the thymus and influences γδ T-cell effector subset
distribution. Hh-mediated transcription in thymic γδ cells increased γδ T-cell number,
and promoted their maturation and increased the γδNKT subset, whereas inhibition
of Hh-mediated transcription reduced the thymic γδ T-cell population and increased
expression of many genes that are normally down-regulated during γδ T-cell maturation.
These changes were also evident in spleen, where increased Hh signaling increased
γδNKT cells, but reduced CD27-CD44+ and Vγ2+ populations. Systemic in vivo
pharmacological Smoothened-inhibition reduced γδ T-cell and γδNKT cells in the thymus,
and also reduced splenic γδ T-cell and γδNKT populations, indicating that Hh signaling
also influences homeostasis of peripheral γδ T-cell populations. Taken together our
data indicate that Sonic Hedgehog is an important determinant of γδ T-cell effector
subset differentiation.
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INTRODUCTION
Gamma delta (γδ) T-cells are a conserved population of lymphocytes, which like αβ T-cells
develop in the thymus. αβ T-cell development and γδ T-cell development diverge at the
CD44+CD25+CD4-CD8- (double negative [DN2]) stage of thymocyte development, during
which rearrangement of β-, γ-, and δ-chains of the TCR is initiated. Strength of TCR signal
is believed to influence the αβ/γδ lineage choice, with stronger signaling leading to γδ T-cell
commitment, and weaker signaling leading to differentiation along the αβ T-cell lineage (1–3).
Thus, successful rearrangement of γ- and δ-chains, and functional expression and signaling though
the γδTCR complex drives differentiation into the γδ T-cell lineage, supported by expression of the
transcription factor Sox13. Cells that have not produced a functional γδTCR, however, undergo
β-selection for differentiation along the αβ T-cell lineage (4, 5).
γδ T-cells first develop before αβ T-cells during ontogeny, with waves of development leading
to distinct subsets of γδ T-cells which home to particular anatomical sites, and use distinct V-γ and
V-δ gene segments. These fetal-derived γδ T-cells can be regarded as innate-like cells, which can
respond rapidly without clonal expansion.
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The adult thymus continues to produce γδ T-cells, which can
be divided into distinct subsets by cell surface markers: as the
CD27+ γδ population matures it downregulates expression of
CD24, and upregulates CD44. The CD27+CD44+ population
contains the NK1.1+ γδ subset (γδNKT cells) which can produce
IL4 or IFNγ, and also includes cells that have a Th1-like
bias of cytokine production (γδT1 cells), whereas the CD27-
CD44+ population is enriched for Vγ2-gene usage and IL17-
producing γδ cells (γδT17), and an additional adaptive γδ T-
cell subset (γδTn) is also produced in the adult thymus (5–8).
The early stages of γδ T-cell development in the thymus can be
further subdivided by expression of cell surface CD25 and CD73,
with the earliest γδTCR+ population being CD25+CD73-,
and acquisition of cell-surface CD73 marking commitment
to the γδ lineage (8–11). In contrast to αβT-helper cell
differentiation in which naïve αβT-cells acquire effector function
and phenotype following activation in the periphery, some γδ
subsets are believed to be pre-committed for differentiation
into their effector subset and functionally-programmed in the
thymus (5–15).
Here we investigate the function of the Hedgehog (Hh)
signaling pathway in γδ T-cell effector subset development in
the thymus. The three mammalian Hedgehog family members
(Sonic Hedgehog [Shh], Desert hedgehog [Dhh], and Indian
hedgehog [Ihh]) signal by binding to their cell surface receptor
Patched1 (Ptch1) (16). Ptch1 then releases its repression of the
signal transducer Smoothened (Smo). At the end of the pathway
are the Gli family of transcription factors (Gli1, Gli2 and Gli3)
(17). Gli1 can only function as an activator of transcription and
is itself a target gene of the signaling pathway. Gli2 and Gli3 are
processed to act as transcriptional activators (Gli2A/Gli3A) when
the signaling pathway is activated, or as transcriptional repressors
(Gli2R/Gli3R) in the absence of Hh proteins.
The pathway has multiple positive and negative feed-back
mechanisms (16, 17). Ptch1 is itself a Hh target-gene, so
that its upregulation can function to sequester Hh proteins
and negatively regulate the pathway, the cell surface molecule
Hedgehog interacting protein (Hhip) can also sequester Hh
proteins, and the small GTP-binding protein Rab23 is a negative
regulator of Hh signal transduction (18).
Shh signaling from thymic epithelial cells (TEC) to developing
thymocytes promotes T-cell development at early stages of
thymocyte development but negatively regulates αβ T-cell
development at the pre-TCR and TCR-dependent transitions
from DN to CD4+CD8+ double positive (DP) and DP to single
positive (SP) cell (19–27). Smo is highly expressed in immature γδ
T–cells (6) and conditional deletion of Smo from T-lineage cells,
and constitutive Shh-deficiency in the fetal thymus reduced the
overall production of γδ cells, consistent with the negative effect
of Smo-deletion or Shh-deficiency on the DN2 population, but
the influence of theHh signaling pathway on γδT-cell maturation
and subset distribution in the thymus was not examined (19, 28).
Hh signaling has also been shown to influence innate immune
cell populations and to promote the proliferation and activation
of murine liver iNKT cells (29–32).
Our study investigated the function of the Hh signaling
pathway in γδ subset distribution in the thymus and in the
homeostasis of γδ T-cell populations in the spleen. We show
that Shh promotes γδ T-cell development in the thymus and
is a determinant of γδ subset distribution, increasing the
γδNKT population.
MATERIALS AND METHODS
Mice
Gli21N2-transgenic (tg) and Gli21C2-tg were as described (23,
33). C57BL/6 mice were from Envigo. GBS-GFP-tg (34) were
provided by J. Briscoe and Shh+/- (35) mice by P. Beachy.
Mice were genotyped using methods and primers as described:
GBS-GFP-tg (21); Gli21N2-tg (23); Gli21C2-tg (33); Shh+/-
(19). Adult mice were between 4 and 6 weeks old. All mice
were backcrossed onto a C57BL/6 background and bred and
maintained at UCL. Mouse studies were approved by the British
Home Office.
In some experiments, mice were treated by intraperitoneal
(i.p.) injections with 40 µg/day of the Smo-inhibitor (Smo-inh)
PF-04449913 (Pfizer) (36, 37) or vehicle control (DMSO) daily
for 14 days.
Flow Cytometry
Cells were stained as described (38), using antibodies from
eBioscience (UK) and analyzed on a C6 Accuri flow cytometer
(BD) or an LSR II (BD). Flow cytometry data were analyzed using
FlowJo version 10.4.1 (Tree star). Live cells were gated according
to FSC/SSC profiles.
Cell Cultures
Fetal thymus organ cultures (FTOC) were carried out as
described (27). In some experiments recombinant (r) Shh (R&D
systems) or rHhip (Sigma) were added at 1 µg/ml.
Quantitative (Q) RT PCR
Lymphocytes were sorted using a MoFlo (Cytomation, Fort
Collins, CO). Cells collected fell within FSC/SSC live gate.
RNA was extracted using Absolutely RNA miniprep kit
(Agilent) or the PicoPure kit (Applied Biosystems). cDNA was
synthesized using High Capacity cDNA reverse transcription
kit (Applied Biosystems). cDNA samples were analyzed on
the iCycler (Bio-Rad Laboratories, Hercules, CA) using SYBR
Green Supermix (Bio-Rad) according to the manufacturer’s
guidelines. RNA levels obtained from each sample were
measured relative to the level of the housekeeping gene Hprt,
as described previously (31). Primers were purchased from
QuantiTect (Qiagen).
RNA Sequencing and Data Analysis
RNA sequencing was carried out as described (39). RNA was
prepared from CD27+CD3+γδ+ cells sorted by FACS by
UCL GOS ICH Flow cytometry facility (>95% purity) from
the adult thymus and extracted using Arcturus PicoPure RNA
Isolation kit (Applied Biosystems) and quantity and quality
determined by Bioanalyser 2100 (Agilent). RNA was sequenced
by UCL Genomics on the Illumina Next Seq 500. Genomic
alignment was carried out by UCL Genomics using STAR v2.5b
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FIGURE 1 | Hedgehog signaling promotes the γδ T-cell population in the thymus. (A) QRT-PCR analysis on CD3+ γδ+ (γδ cells), CD4+CD8+ (DP),
CD4-CD8-CD25+ (DN2/DN3) populations (purified by FACS), and the whole unfractionated thymus (thymus) from 4 week-old WT mice. Expression of Sox13, Smo,
Ptch1, Gli1, and Rab23 are shown (relative to Hprt). Bar charts show mean ± SEM from three independent experiments (biological replicates). (B) Representative
histogram shows GFP-fluorescence, gated on CD3+γδ+ cells from GBS-GFP-tg thymus, giving the percentage in the marker shown. Dot plot shows representative
anti-CD24 staining against GFP-fluorescence from GBS-GFP-tg thymus, giving the percentage of cells in the quadrants shown. Bar charts show mean ± SEM
percentage of GFP+ cells, gating on CD3+γδ+ and CD3+γδ+CD24+ cells from GBS-GFP-tg thymus (n = 3). (C,D) E14.5 WT FTOC were cultured for 5 days with
rShh (1µg/ml) or without treatment (control) and analyzed by flow cytometry. Each data point represents an individual thymus lobe. (C) Number of CD3+γδ+ cells
recovered per thymus lobe for untreated (Control, n = 6) and rShh-treated (n = 6). (D) Percentage of CD44+ cells, gated on CD3+γδ+ cells recovered per thymus
lobe for untreated (Control, n = 6) and rShh-treated (n = 6). (E) E16.5 WT FTOC were cultured for 5 days with rHhip (1µg/ml) or without treatment (control) and
analyzed by flow cytometry. Each data point represents an individual thymus lobe. Scatter plot shows the number of CD3+γδ+ cells recovered per thymus lobe for
untreated (Control, n = 6) and rHhip-treated (n = 6). Each data point represents thymus from an individual embryo. *p < 0.05; ***p < 0.005.
(via Illumina BaseSpace). The RNA sequencing dataset was
processed and standardized using the Bioconductor package
DESeq2, which was used to generate normalized estimates of
transcript abundance, expressed as RPKM (reads per kilobase
of transcript per million mapped reads). Data analysis was
carried out as described (39, 40). Differentially expressed genes
(DEG) were determined using moderated Ebayes t-statistic (P
< 0.05) from the limma package in Bioconductor. Selection
of transcription factors from DEG lists was carried out using
PANTHER (41). Canonical Correspondence Analysis (CCA) was
performed to compare the datasets to external publicly available
datasets, as described in Ono et al. (42), using the CRAN
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FIGURE 2 | Shh and Smo promote γδ cell differentiation and influences γδ subset distribution in adult thymus. (A–D) Flow cytometry of adult Shh+/+ (WT, n =
3) and Shh+/- (n= 3) littermate thymus. (A)Dot plot shows anti-CD3 against anti-γδ staining from representativeWT and Shh+/- littermate thymus, giving the percentage
(Continued)
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FIGURE 2 | of cells in the region shown. Scatter plot shows the number of CD3+γδ+ cells recovered. (B) Representative histogram overlays show anti-CD24
staining, gated on CD3+γδ+ in WT (dark shade) and Shh+/- (light shade) adult thymus, giving the MFI. Left-hand scatter plot shows the percentage of CD24hi cells
(that fall within the marker shown on the histogram). Middle scatter plot shows MFI of anti-CD24 staining gated on CD3+γδ+ cells. Right-hand scatter plot shows the
number of CD24+CD3+γδ+ cells in WT and Shh+/- littermate thymus. (C) Representative dot plot shows CD27 and CD44 expression, gated on CD3+γδ+ cells,
giving the percentage of cells in the quadrants. The scatter plot shows the percentage of CD27+CD44+ cells, gating on CD3+γδ+ cells. (D) Representative
histogram shows NK1.1 expression, gated on CD3+γδ+ cells, giving the percentage of cells in the marker. The scatter plot shows the percentage of NK1.1+ cells,
gating on CD3+γδ+ cells. (E–G) Adult WT mice were injected ip with 40 µg/day of the Smo-inhibitor (Smo-Inh) PF-04449913 (Pfizer) (n = 10) or vehicle control
(DMSO) (n = 10) daily for 14 days and thymus analyzed by flow cytometry. (E) Representative dot plot shows FSC vs. SSC to show the live gate used.
(F) Representative dot plot shows CD3 and γδ expression in control and Smo-Inh-treated thymus. Scatter plot shows number of CD3+γδ+ cells recovered per
thymus from control and Smo-Inh-treated mice. (G) Representative histogram shows NK1.1 expression, gated on CD3+γδ+ cells from control and Smo-Inh-treated
thymus. Scatter plots show the percentage (left) and number (right) of NK1.1+ cells, gated on CD3+γδ+ cells, per thymus from control and Smo-Inh-treated mice. In
all scatter plots in this figure, each point represents an individual mouse and bars show mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.005.
package vegan. Heatmaps were generated using the CRAN
package pheatmap and RColorBrewer: rows were centered; unit
variance scaling was applied to rows; and rows were clustered
using Pearson correlation distance and average linkage. Principal
component analysis (PCA) was performed using normalized
transcript expression values, using the built-in R function pca.
The CRAN package factoextra was used to extract the list
of contributing genes and then they were plotted using the
package ggplot2. The RNA sequencing data are publicly available
(GEO: GSE113468).
Statistical Analysis
Unpaired two-tailed student’s t-test using data from at least
three independent experiments was used to test the significance
of differences observed in WT and mutant mice, unless stated
otherwise. ∗p< 0.05; ∗∗p< 0.01; ∗∗∗p< 0.005.
RESULTS
Hh Components Are Expressed by Thymic
γδ T-Cells
We first assessed if thymic γδ T-cells express components of the
Hh signaling pathway and actively transduce Hh signals. We
purified CD3+γδTCR+ cells by FACS from adult WT thymus
and assessed gene expression by QRT-PCR, compared to FACS-
purified CD4+CD8+ (DP) and CD25+CD4-CD8- (DN2/3)
populations and unsorted thymus cell suspension (Figure 1A).
As expected, the sorted γδ T-cells showed high expression of
Sox13, which was not detected in other populations examined.
We also detected expression of Smo [as expected (6)], and the
Hh target genes and pathway components Ptch1 and Gli1 in
γδ T-cells, and as previously reported in DP and DN2/3 cells
(20, 23, 25, 28). The negative regulator Rab23 was detected in all
three subsets examined, with lower expression in the γδ T-cells
and DN2/3 cells, and higher expression in the DP cells.
To confirm that thymic γδ T-cells transduce Hh signals in
vivo, we made use of Gli binding site (GBS)-GFP-transgenic
reporter mice (Hh reporter mice) (34). Gating on CD3+γδTCR+
thymocytes, we found that ∼5% of thymic γδ T-cells expressed
GFP, which reports Hh-mediated transcription (Figure 1B). The
majority of GFP+ CD3+γδTCR+ thymocytes were CD24+,
indicating that levels of Hh-mediated transcription were highest
in immature γδ T-cells.
Hh Signaling Promotes Fetal Thymic γδ
T-Cell Production in vitro
Given that thymic γδ T-cells can transduce Hh signals, we
tested the impact of treatment with recombinant (r) Shh and
the Hh-neutralizing protein rHhip, on γδ T-cell development
in FTOC. Treatment with rShh significantly increased the
number of CD3+γδTCR+ cells recovered from WT FTOC,
and significantly increased the proportion of the more mature
CD44+ cells (Figures 1C,D). In contrast, treatment with rHhip
significantly reduced the number of γδ T-cells recovered
(Figure 1E). Thus, Hh signaling promoted γδ T-cell production.
Interestingly, this is opposite to the effect of Hh on αβ T-cell
development in FTOC, where Hh-neutralization promotes αβ
T-cell maturation (22, 23, 26, 27), suggesting that Hh signaling
may influence the γδ/αβ lineage choice.
Shh Promotes γδ T-Cell Development and
Increases the γδNKT Population in the
Adult Thymus
We next investigated if Hh signaling also increased γδ T-cell
populations in adult thymus. As Shh-deficiency is embryonic
lethal, we examined the thymus of adult Shh+/- mice. The adult
Shh+/- thymus contained significantly fewer γδ T-cells than WT
(Figure 2A). Cell surface CD24 expression was higher on the
CD3+γδTCR+ population, indicating a less mature phenotype
(Figure 2B). Interestingly, the number of CD24+CD3+γδTCR+
cells (cells that stained highly and fell within the positive
marker shown in the histogram) recovered from the Shh+/-
thymus was not significantly lower than in the WT, showing
that in the Shh+/- thymus the γδ population is enriched for
immature cells and the more mature CD24low/negative γδ T-cell
population is reduced (Figure 2B). Consistent with this, within
the Shh+/- CD3+γδTCR+ population, there was a significant
decrease in the proportion of CD27+CD44+ cells compared
to WT (Figure 2C), and the Shh+/- CD3+γδTCR+ population
contained significantly fewer γδNKT cells than WT (Figure 2D).
Pharmacological Smo-Inhibition Reduces
Adult Thymic γδ T-Cell Populations in vivo
We then tested if in adult mice, inhibition of the Hh pathway
in vivo by treatment with a pharmacological Smo-inhibitor
influenced γδ T-cell populations in theWT thymus. After 14 days
treatment in vivo by i.p. injection, the CD3+γδTCR+ population
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FIGURE 3 | Hh-mediated transcription promotes γδ T-cell development and influences γδ subset distribution in adult thymus. (A) The proportion and number of
CD3+γδ+ cells recovered from WT (n = 3) and Gli21C2-tg (n = 3) littermate adult thymus. (B) Representative dot plots show CD25 and CD73 expression, gated on
(Continued)
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FIGURE 3 | CD3+γδ+ cells from WT and Gli21C2-tg, giving the percentage of cells in the CD25+CD73- region shown. Scatter plots show the percentage of
CD25+CD73- cells, gated on CD3+γδ+ (left) and number of CD25+CD73-CD3+γδ+ cells recovered (right) from WT (n = 3) and Gli21C2-tg (n = 3). (C–G) Flow
cytometry analysis of WT (n = 3) and Gli21N2-tg (n = 3) littermate adult thymus. (C) The proportion and number of CD3+γδ+ cells recovered. (D) Representative dot
plots show CD25 and CD73 expression, gated on CD3+γδ+ cells from WT and Gli21N2-tg, giving the percentage of cells in the CD25+CD73- region shown. Scatter
plots show the percentage of CD25+CD73- cells, gated on CD3+γδ+ (left) and number of CD25+CD73-CD3+γδ+ cells recovered (right). (E) Representative
histograms show anti-CD24 staining, gated on CD3+γδ+. Scatter plots show the percentage of CD24+ cells, gated on CD3+γδ+. (F) Representative dot plot shows
anti-CD27 and anti-CD44 staining, gated on CD3+γδ+, giving the percentage of cells in each quadrant. Scatter plot shows the percentage of CD27+CD44+ cells,
gated on CD3+γδ+. (G) Representative dot plot shows anti-NK1.1 staining against SSC, gated on CD3+γδ+CD44+CD27+, giving the percentage of NK1.1+ cells
in the region shown. Middle scatter plot shows the percentage of NK1.1+ cells, gated on CD3+γδ+CD44+CD27+. Representative histogram overlays show
intracellular anti-PLZF staining, gated on CD3+γδ+ (dotted lines) and on CD3+γδ+NK1.1+ (dark shading) and isotype control staining (light shade) on WT (upper)
and Gli21N2-tg (lower) thymus. Scatter plots how the percentage of PLZF+ cells (cells within the marker in the histogram), gated on CD3+γδ+ (upper plot) and on
CD3+γδ+NK1.1+ (lower plot). In all scatter plots in this figure, each point represents an individual mouse and bars show mean ± SEM. *p < 0.05; **p < 0.01;
***p < 0.005.
in the thymus was significantly decreased in the Smo-inhibitor-
treated mice, compared to vehicle (DMSO)-treated controls
(Figures 2E,F). Treatment with the Smo-inhibitor also caused a
significant reduction in the proportion and number of γδNKT
cells in the thymus (Figure 2G), consistent with the Shh+/- adult
thymus (Figure 2D).
Hh-Mediated Transcription in T-Lineage
Cells Promotes γδ T-Cell Maturation
As rShh-treatment increased γδ T-cell populations in FTOC,
and Smo-inhibition and Shh-mutation reduced γδ T-cells in
adult thymus in vivo, we next tested if these changes were the
direct result of Hh pathway activation in developing T-lineage
cells or were due to indirect effects by other cell types in the
thymus. To do so, we used transgenic mice which express
modified forms of Gli2 that can function as transcriptional
activator only (Gli21N2-tg) or transcriptional repressor only
(Gli21C2-tg) in T-lineage cells from the DN2 stage onwards (23,
33). Inhibition of normal physiological levels of Hh-mediated
transcription in the adult Gli21C2-tg thymus significantly
reduced the proportion and number of CD3+γδTCR+ cells in
the thymus compared to WT (Figure 3A), and the proportion
and number of the earliest CD3+γδ+CD25+CD73- stage was
also significantly reduced (Figure 3B). In contrast, increasing
Hh-mediated transcription in thymocytes to above WT levels
in the adult Gli21N2-tg led to a significant increase in
the proportion and number of CD3+γδTCR+ cells, and the
proportion and number of the earliest CD3+γδ+CD25+CD73-
population was also significantly increased (Figures 3C,D).
Active Hh-mediated transcription also influenced later stages
of γδ T-cell maturation and differentiation. We observed a
significant decrease compared to WT in the proportion of
immature CD24high cells, gating on CD3+γδTCR+ (Figure 3E),
whereas the proportion of CD27+CD44+ cells was significantly
increased (Figure 3F). The CD3+γδ+NK1.1+CD27+CD44+
(γδNKT) population was significantly increased in the Gli21N2-
tg thymus compared to WT (Figure 3G), and expression of
the transcription factor PLZF, which is required for γδNKT
cell development and function (43), was significantly higher in
the CD3+γδ+NK1.1+ population in the Gli21N2-tg thymus
(Figure 3G). Thus, increased Hh-mediated transcription in
thymocytes to above WT levels led to an overall increase in
the number of γδ T-cells in the adult thymus (Figure 3C),
and also changed the subset distribution within the CD3+γδ+
population, with an increase in the earliest CD25+CD73-
population, consistent with the overall increase in γδ T-cells, and
also an increase in the PLZF+ γδNKT population.
Hh Signaling Influences the Maturation
Status and Transcriptional Signature of
Thymic γδ Populations
To investigate the impact of Hh pathway activation on
the transcriptional signature and differentiation of thymic
γδ populations, we carried out RNA sequencing on
CD3+γδTCR+CD27+ cells purified by FACS from Gli21N2-tg,
Gli21C2-tg and WT thymus (Figures 4, 5).
In order to confirm that both transgenes were active in
developing γδ T-cells and were able to inhibit or increase the
levels of Hh-mediated transcription, we first used canonical
correspondence analysis (CCA) to compare our datasets to
publicly available transcriptome datasets: we generated a scale
of inhibited-to-active Hh signaling, using transcriptome datasets
from resting CD4 T-cells from Gli21N2-tg and Gli21C2-
tg [(44) GEO: GSE33156]. As expected, when we plotted
the six samples against this scale, the samples segregated by
genotype, with the Gli21N2-tg γδ T-cells scoring highly on the
Hh-activated scale, the Gli21C2-tg γδ T-cells scoring highly in
the inhibition-of-Hh signaling axis, and WT samples scoring
intermediate (Figure 4A).
The datasets contained many differentially expressed
genes (DEG) between genotypes, with levels of Hh-mediated
transcription influencing expression of genes associated with
differentiation, signaling, and lymphocyte function. Therefore, in
order first to determine the transcriptional influence of normal
levels of Hh signaling on thymic CD3+γδTCR+CD27+ cells,
we used EBayes statistics to identify 820 DEG genes between
Gli21C2 and WT datasets (Supplementary Table 1). Then,
to investigate if these Hh-regulated genes are important in
γδ T-cell maturation, we intersected the 820 DEG with a list
of γδ maturation signature genes (495 genes) that increase
or decrease upon maturation of γδ T-cells, as defined by
a published transcriptome analysis of immature γδ T-cells
(CD24hi) and mature γδ T-cells (CD24lo) from adult thymus
from the Immunological Genome Project Consortium (6).
The intersection revealed 22 common elements (Figure 4B),
13 of which were more highly expressed in the Gli21C2
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FIGURE 4 | Influence of Hh signaling on the transcriptional pattern of thymic CD27+CD3+γδ+ cells. RNA sequencing was carried out on CD27+CD3+γδ+
thymocytes (purified by FACS) from WT, Gli21N2-tg, and Gli21C2-tg. Two datasets from independent sorts (biological replicates) were carried out for each genotype.
(Continued)
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FIGURE 4 | (A) Canonical correspondence analysis (CCA) was used to generate a scale of Hh-inhibition to active Hh signaling and our datasets were plotted against
this scale, where the negative half of the y-axis represents Hh-inhibition and the positive half increasing score of active Hh signaling. (B) The Venn diagram illustrates
the intersection between the DEG list of Gli21C2-vs.-WT with the published list of γδ maturation signature genes to identify genes that are regulated by physiological
levels of Hh signaling and also contribute to γδ T-cell maturation. (C) The Pearson correlation clustering heatmap shows expression in WT and Gli21C2 of the 22 DEG
between Gli21C2-vs.-WT from the intersection in (B), where red represents higher expression and blue lower expression on a linear correlation scale. A value of 1
indicates a positive association, while a value of −1 indicates a negative association, and a value of 0 indicates no association. Gene names given in blue are genes
that are downregulated during γδ maturation, whereas gene names given in red are genes which are upregulated during γδ maturation. (D) The Venn diagram
illustrates the intersection between the DEG list of Gli21N2-vs.-WT with the published list of γδ maturation signature genes to identify genes that are influenced by
increasing levels of Hh signaling and also contribute to γδ T-cell maturation. (E) The Pearson correlation clustering heatmap shows expression in WT and Gli21N2 of
the 33 DEG between Gli21N2- vs.-WT from the intersection in (D), where red represents higher expression and blue lower expression on a linear correlation scale. A
value of 1 indicates a positive association, while a value of −1 indicates a negative association, and a value of 0 indicates no association. Gene names given in blue
are genes that are downregulated during γδ maturation, whereas gene names given in red and genes which are upregulated during γδ maturation. (F) The Pearson
correlation clustering heatmap shows expression of selected DEG (P < 0.05 by Ebayes) from WT and Gli21C2 datasets where red represents higher expression and
blue represents lower expression on a linear correlation scale. A value of 1 indicates a positive association, while a value of −1 indicates a negative association, and a
value of 0 indicates no association. (G) The Pearson correlation clustering heatmap from WT and Gli21N2 datasets shows expression of selected DEG (P < 0.05 by
Ebayes) where red represents higher expression and blue represents lower expression on a linear correlation scale. A value of 1 indicates a positive association, while
a value of −1 indicates a negative association, and a value of 0 indicates no association.
datasets than WT and therefore are normally down-regulated
by Hh signaling, and these were all genes that have been
shown to be downregulated as γδ T-cells mature. Nine DEG,
however, showed lower expression in the Gli21C2 datasets,
and so are normally upregulated by Hh signaling. Six of
these, including Cd44, are upregulated as γδ T-cells mature
(Figure 4C). Thus, the transcriptional signature induced by
physiological levels of Hh signaling in the CD27+CD3+γδ+
thymocyte population promoted γδ T-cell maturation, but
inhibition of Hh-mediated transcription also affected the
expression of many genes that have not been associated with γδ
T-cell maturation.
Next, we investigated how increasing levels of Hh-mediated
transcription to above normal WT levels influenced the pattern
of gene expression, by comparison of Gli21N2 andWT datasets.
Ebayes statistics identified 1218 DEG (Supplementary Table 2)
and intersection of these with the 495 γδ maturation signature
genes highlighted 33 genes which are regulated by increasing the
level of Hh signaling and are also important in γδ maturation
(Figure 4D). Nineteen of these DEG were downregulated in
the Gli21N2 datasets and importantly these are also all
genes that are known to be downregulated as γδ thymocytes
mature (Figure 4E). These down-regulated genes included
Nr4a3, which is a transcriptional target of TCR-signaling (45),
so its down-regulation is consistent with the reduced TCR-
signal strength observed in Gli21N2-tg thymocytes (23, 25). In
contrast, of the 14 intersection genes that had higher expression
in the Gli21N2 datasets, 11 were genes that are also upregulated
during γδ T-cell maturation, including ICOS, which is highly
expressed in γδNKT lineage cells in the thymus (8) and can signal
to reduce development of the γδ17 population (46). Increased
expression of Clec12a (Cd371), was consistent with the increase
in CD25+CD73-CD3+γδ+ cells in the Gli21N2-tg thymus
(Figure 3D), as it is highly expressed on the most immature γδ
populations, and its expression remains high in precursors of the
γδTn population (8). Taken together, the DEG betweenGli21C2-
vs.-WT datasets, and between Gli21N2- vs.-WT datasets both
indicate that during γδ T-cells maturation in the thymus Hh
pathway activation signals to promote maturation, both by
downregulation of genes associated with immature γδ T-cell
populations and upregulation of genes required for maturation.
This is supported by our FTOC and ex vivo analysis of thymic γδ
T-cells populations. Increasing the Hh signal (by rShh treatment;
and Gli21N2 transgene expression) increased maturation of γδ
T-cells in the thymus. In contrast, reduction in Hh signaling to
below normal physiological levels (by Shh-mutation; Gli21C2
transgene expression; rHhip treatment in vitro; and Smo-
inhibitor treatment in vivo) reduced the γδ T-cell populations in
the thymus.
Further comparison between the Gli21C2-tg and WT
datasets revealed many genes important in signal transduction
or immune function that were regulated by inhibition
of physiological levels of Hh-mediated transcription in
CD27+CD3+γδ+ cells (Figure 4F). Amongst down-
regulated DEG were the chromatin remodeling gene Chd7;
the microtubule-associated motor protein Kif21b and the
BBSome complex member Bbs2, both of which are involved
in cilia transport and morphogen signaling; the chemokine
Cxcl17; members of the Rab GTPase family (Rab5b, Rab19),
which function as regulators of intracellular vesicle transport;
and several adhesion molecules (Icam1, Cd22, Cd209a, Itga2b,
and Icam4). DEG upregulated in Gli21C2-tg compared to WT
datasets also included several members of the Rab GTPase family
(Rab10, Rab6b, Rab42, Rab28, Rab32); the homeobox gene
Hoxa3; BBSome complex member Bbs9; the B7 family member
Cd276; and the transcription factor Klf8. The guanine nucleotide
exchange factor Vav3 was also upregulated when normal levels
of Hh-mediated transcription were reduced, consistent with
previous findings that Hh pathway activation can reduce TCR
signal strength in αβ T-cells, and with its higher expression in
immature γδ T-cells (6, 21, 23, 25, 26, 33, 47, 48).
Increased Hh-mediated transcription to above normal
levels, in the Gli21N2-tg CD27+CD3+γδ+ thymocytes also
influenced levels of expression of several Rab family members
(down-regulation of Rab4a, upregulation of Rab14, and
Rab8a); and influenced expression of many genes associated
with immune function and/or TCR signaling (including
downregulation compared to WT of Tnfsf9, Cd72, Dusp4,
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FIGURE 5 | Comparison of Gli21N2 and Gli21C2 datasets to investigate the influence of Hh signaling on the transcriptional pattern of thymic CD27+CD3+γδ+
cells. Further analysis of the RNA sequencing datasets (as in Figure 4): two datasets from independent FACS sorts (biological replicates) of CD27+CD3+γδ+
thymocytes from Gli21N2-tg and Gli21C2-tg thymus. (A) The Pearson correlation clustering heatmap shows expression in Gli21N2 and Gli21C2 of 57 DEG that
encode transcription factors (identified by PANTHER), where red represents higher expression and blue lower expression on a linear correlation scale. A value of 1
indicates a positive association, while a value of −1 indicates a negative association, and a value of 0 indicates no association. (B) Principle component axis 1
(PC1) for Gli21N2 andGli21C2DEG, showing some genes that contributed to the negative (Gli21C2) and positive (Gli21N2) PC1 axis. (C) Pearson correlation clustering
(Continued)
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FIGURE 5 | heatmap of DEGs identified by intersection analysis between the DEG (P < 0.05 by Ebayes) and genes that highly contributed to the negative and
positive PC1 axis (genes that scored >0.80 and <-0.80), illustrating some genes that contribute to γδ T-cell maturation and Hh signaling. Red represents higher
expression and blue represents lower expression on a linear correlation scale. A value of 1 indicates a positive association, while a value of −1 indicates a negative
association, and a value of 0 indicates no association. (D) The Pearson correlation clustering heatmap from Gli21C2 and Gli21N2 datasets shows expression of
selected DEG (P < 0.05 by Ebayes) where red represents higher expression and blue lower expression on a linear correlation scale. A value of 1 indicates a positive
association, while a value of −1 indicates a negative association, and a value of 0 indicates no association.
Trim46, Nr4a3, Nr4a1, Tcf3, Socs5; upregulation of Nfkbia, Cd8a,
Cd4, Socs2, Cd52, Trim21); and influenced genes associated
with Hedgehog (Kif3c, Disp1) and Notch (Adam15, Maml2)
pathways (Figure 4G). Expression of the transcription factor
Klf2 was significantly lower in the Gli21N2-tg datasets than WT
(Figure 4G). This is of interest given that Klf2 is required for γδ
T-cell thymic egress and its deficiency results in an increase in the
incidence of γδNKT cells, many of which expressed CD4 (49).
To investigate further the influence Hh-mediated
transcription on thymic γδ T-cell development we then
filtered DEG between Gli21C2 and Gli21N2 datasets for
genes that encode transcription factors, in order to identify
potential developmental regulators down-stream of Hh-
mediated transcription (Figure 5A). Expression of the Notch
target genesHes1 andHey1 were higher in the Gli21C2 datasets,
suggesting that inhibition of Hh pathway activation led to
increased Notch signal transduction, of interest given that
the Notch-Hes1 pathway is required for development of γδ17
cells (50). Interestingly, Ahr was also higher in the Gli21C2
datasets, and high levels of Ahr expression are associated with
IFNγ-producing γδ intraepithelial lymphocytes (51, 52) and
the IFNγ-producing non-NKT γδ population (γδT1) in the
thymus (8).
Next, to compare Gli21C2 and Gli21N2 datasets in an
unbiased manner, we carried out Principal component analysis
(PCA) on normalized expression values between the datasets.
PCA separated datasets by genotype on Principal component
(PC)1 (Figure 5B), which accounted for 43.76% of variance.
Genes that contributed strongly to the positive axis (with higher
expression in Gli21N2 datasets) included: Bcl6; Hh-associated
genes (including Dzip1 and Gsk3b); and NK-associated genes
(including Klra18 and Tyrobp). Genes that contributed strongly
to the negative axis (higher expression in Gli21C2 datasets)
included Sox13 and the Hh signal transduction molecule Smo,
which are both more highly expressed in immature thymic γδ
populations (6, 8). To highlight DEG that are important for
the differences between genotypes, we intersected the genes
that contributed most to PC1 with the DEG (p < 0.05)
between Gli21C2 and Gli21N2 datasets (Figure 5C). DEG of
interest included Il1a, which was more highly expressed when
Hh-mediated transcription was increased, whereas genes that
were increased when Hh-mediated transcription was inhibited
included Il4ra, the Bcl6-co-repressor Bcor, the Myc-pathway
geneMxd1.
Finally, we selected DEG whose level of expression is known
to correspond to distinct stages of γδ T-cell development or
γδ T-cell subsets or to be induced by γδTCR signaling in the
thymus (8, 53). Expression of Egr1, Egr2, Nr4a1, Mki67, which
have been shown to be upregulated by TCR signaling, were
higher in Gli21C2 cells, as were the signaling molecules Lat2 and
Gab2 (Figure 5D). Constitutive Hh-mediated transcription led
to upregulation of genes that are highly expressed by the thymic
γδNKT population (Il23r, Icos, Tnf, Il17a), supporting the notion
that Hh pathway activation promotes the γδNKT population in
the thymus (Figure 5D). We also observed increased expression
of Rorc, Slamf1, and Clec12a (Cd371), which are more highly
expressed in the adult thymic precursors of the TCR-naive
adaptive γδ T-cells (γδTn) (8).
Influence of Hh Signaling on Spleen
γδ Subsets
As mutation of Hh pathway components caused
profound changes in the transcriptional signature of
CD27+CD3+γδTCR+ cells in the thymus, and Hh signaling
increased the thymic γδNKT population, which migrate to the
spleen, we investigated γδ T-cell subsets in the spleen. First, to
test if they respond to Hh signals, we compared expression of
Ptch1, Smo, and Gli1 by QRT-PCR on RNA prepared from WT
splenic FACS-purified CD3+γδ+ cells to their expression in
FACS-purified CD4+ and CD8+ αβT-cells, which are known
to express Hh pathway components and transduce Hh signals
(23, 47, 54). Smo was expressed at similar levels in γδ T-cells as
in the CD4+ αβ T-cell population, whereas expression of the
target genes Ptch1 and Gli1 were lower than in the αβ T-cell
populations (Figure 6A). Analysis of the GBS-GFP transgenic
spleen indicated that∼4% of γδ T-cells expressed GFP (reporting
Gli-mediated transcription). The majority of GFP+ γδ T-cells
belonged to the less mature CD24+ subset, suggesting that levels
of Hh-mediated transcription were highest in immature γδ
T-cells in the spleen (Figure 6B).
Therefore, to test if splenic γδ T-cell homeostasis is
still sensitive to modulation of Hh pathway activation,
we investigated the impact of systemic Smo-inhibition on
splenic γδ+ populations in vivo, after 14 days treatment
with Smo-inhibitor or DMSO-control. Smo-inhibition led
to a significant reduction in the proportion and number
of CD3+γδ+ cells in the spleen (Figure 6C). When gating
on the CD3+γδ+ population, we observed a significant
increase in the proportion of CD27+CD44- cells in the Smo-
inhibitor treated group compared to control, although the
number of CD27+CD44-CD3+γδ+ cells was in fact lower
than in the control, as a result of the overall decrease in
CD3+γδ+ cells (Figure 6D). There was a significant decrease
in the proportion of CD27+CD44+ cells and a significant
decrease in their number (Figure 6E). The proportion and
number of CD3+γδ+NK1.1+ cells were also significantly
reduced in spleen (Figure 6F), whereas the proportion of
Vγ2+ cells (gated on CD3+γδ+) was significantly increased
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FIGURE 6 | Hh signaling is active in spleen γδ cells and influences spleen γδ subset distribution and homeostasis. (A) QRT-PCR analysis on CD3+γδ+,
CD3+CD4+CD8-, and CD3+CD4-CD8+ populations (purified by FACS) from spleen from 4 week-old WT mice. Expression of Smo, Ptch1, and Gli1 are shown
(Continued)
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FIGURE 6 | (relative to Hprt). Bar charts show mean ± SEM from three independent experiments (biological replicates). (B) Representative histogram shows
GFP-fluorescence, gated on CD3+γδ+ cells from GBS-GFP-tg spleen, giving the percentage of GFP+ cells in the marker shown. Representative contour plot shows
anti-CD24 staining against GFP-fluorescence from GBS-GFP-tg spleen, giving the percentage of cells in the quadrants. Bar chart shows the mean ± SEM percentage
of GFP+ cells, gated on CD3+γδ+ cells, and gated on CD3+γδ+CD24+ cells from GBS-GFP-tg (n = 3) spleen. (C–G) Adult WT mice were injected ip with 40µg/day
of the Smo-inhibitor (Smo-inh) PF-04449913 (Pfizer) (n = 13) or vehicle control (DMSO) (n = 13) daily for 14 days and spleen analyzed by flow cytometry. (C)
Representative dot plot shows anti-CD3 and anti-γδ staining on spleen cells from control and Smo-inhibitor treated mice, giving the percentage of CD3+γδ+ cells in
the region shown. Scatter plots show the percentage and number of CD3+γδ+ cells in the spleen. (D) Scatter plots show the percentage and number of
CD27+CD44- cells, gated on CD3+γδ+ from control and Smo-inhibitor treated mice. (E) Scatter plots show the percentage and number of CD27+CD44+ cells,
gated on CD3+γδ+ in the spleen from control and Smo-inhibitor treated mice. (F) Representative dot plot shows anti-NK1.1 staining vs. SSC, gated on CD3+γδ+
spleen cells from control and Smo-inhibitor treated mice, giving the percentage of cells in the region shown. Scatter plots show the percentage and number of NK1.1+
cells, gated on CD3+γδ+ in the spleen from control and Smo-inhibitor treated mice. (G) Representative histogram shows anti-Vγ2 staining, gated on CD3+γδ+ cells
in the spleen from control and Smo-inhibitor treated mice. Scatter plots show the percentage and number of Vγ2+ cells, gated on CD3+γδ+ cells in the spleen from
control and Smo-inhibitor treated mice. In all scatter plots in this figure, each point represents an individual mouse and bars show mean ± SEM. *p < 0.05; **p < 0.01.
in the spleen upon Smo-inhibition while the number of
CD3+γδ+Vγ2+ cells was not significantly different from
control (Figure 6G). Thus, the Smo-inhibitor treatment changed
the γδ subset distribution in the spleen, and particularly
reduced the γδNKT population, but did not appear to affect the
Vγ2+ population.
In contrast, the γδ population and CD27/CD44 subset
distribution in the Gli21N2-tg spleen mirrored that of the
Gli21N2-tg thymus and was consistent with the thymus
transcriptome data, with a significant increase in the number
of γδ T-cells in the spleen, but a significant decrease in
the proportion of CD44+CD27- cells (Figures 7A,B). As
transcription of Rorc, Slamf1, and Clec12a were increased in
the Gli21N2 CD27+CD3+γδ+ population (Figure 5D),
we examined the TCR-naive γδTn, which have been
described to be CD3+γδ+CD25-CD371-CD200-CD73-
cells (8). The proportion and number of this population were
significantly increased in the Gli21N2 spleen compared to WT,
suggesting that increased Hh pathway activation promotes their
development or proliferation (Figure 7C). Gating on CD3+γδ+
cells, the proportion of Vγ2+ cells was decreased by more than
4-fold (Figure 7D), consistent with the significant reduction in
the CD27-CD44+ population (Figure 7B). As in the thymus,
the γδNKT population was significantly increased by more than
2-fold in the Gli21N2 spleen compared to WT (Figure 7E).
DISCUSSION
Here we show that Shh signaling in the thymus is a determinant
of γδ T-cell maturation and subset distribution. Increased Hh
signaling in vivo by constitutive expression of a transgenic
activator-only form of Gli2 in T-lineage cells, and in vitro by rShh
treatment of FTOC promoted maturation of γδ T-cells in the
thymus. In contrast, reduction in Hh pathway activation in vivo,
by conditional inhibition of normal Hh-mediated transcription
in T-lineage cells, by mutation of Shh, and by systemic
pharmacological Smo-inhibition, reduced γδ T-cell populations
in thymus and spleen. Hh pathway activation favored the
γδNKT population in both thymus and spleen, but also
influenced multiple stages of development and subsets, including
the earliest immature CD25+CD73-CD3+γδ+ cells, and the
subset distribution between CD27-CD44+Vγ2+, γδNKT, and
γδTn populations.
Our experiments showed that Shh is required for adult thymic
γδ T-cell maturation, as its mutation (in Shh heterozygote)
not only led to a reduction in γδ T-cell numbers, but to an
enrichment of the CD24hi immature subset, and reduction in
expression of the maturation marker CD44, as well as a reduced
thymic γδNKT population. These effects were the result of direct
signaling to developing thymocytes, as conditional inhibition
of normal Hh-mediated transcription (in Gli21C2 thymus)
also reduced γδ T-cell numbers, and reduced the number and
proportion of the earliest CD25+CD73- subset, indicating that
Hh pathway activation promotes the earliest stages of γδ T-
cell development. This was supported by the increase in this
CD25+CD73- population when Hh-mediated transcription was
increased to above normal levels in the Gli21N2-tg thymus.
We used RNA sequencing to investigate the differentiation
status of the thymic CD27+CD3+γδ+ population. This analysis
confirmed that physiological levels of Hh signaling promote γδ
T-cell development in the thymus, as inhibition or increase in
normal levels of Hh-mediated transcription regulated expression
of many genes that are involved in γδ T-cell maturation.
In αβT-cells, Hh pathway activation has been shown to reduce
TCR signal strength (47), and strong TCR signaling has been
proposed to favor γδ T-cell fate over αβ T-cell fate in DN cells (2).
However, although our RNA sequencing datasets also indicated
that Hh pathway activation in thymic γδ T-cells modulated
expression of genes and pathways which are involved in TCR
signal transduction (Vav3, Nfkbia) (55) or are transcriptional
targets of the TCR (Nr4a3, Nr4a1, Egr1, Egr2) (45), the overall
impact of Hh-mediated transcription was the promotion of γδ T-
cell development andmaturation from the earliest CD25+CD73-
stages, independently of any influence on TCR signal strength.
Signaling through the γδTCR also influences γδ T-cell
differentiation after divergence from the αβ lineage: γδT17
development is believed to occur in the absence of TCR ligation,
but γδTCR signaling is required for both γδT1 and γδNKT
populations, and attenuation of TCR-signaling leads to expansion
of γδNKT cells, suggesting that strong γδTCR signals favor
differentiation of the γδT1 population (7, 53, 56, 57). Therefore,
the impact of Hedgehog pathway activation on TCR signal
strength may provide one explanation for the increase in γδNKT
cells observed in the Gli21N2 thymus; and the increase in
Ahr, Hes1, and Heyl expression in the Gli21C2 thymic γδ
cells, as these genes are associated with the γδT1 population.
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FIGURE 7 | Hh-mediated transcription in γδ T-cells influences γδ T-cell populations in adult spleen. (A–D) Gli21N2-transgenic and WT littermate spleens were
analyzed by flow cytometry. In scatter plots each point represents data from a different mouse; bars show mean ± SEM. (A) The number of CD3+γδ+ cells in the
spleen. (B) Representative dot plot shows anti-CD27 and anti-CD44 staining gated on CD3+γδ+ cells from WT and Gli21N2-tg spleen, giving the percentage of cells
in the regions shown. Scatter plot shows the percentage of CD27-CD44+ cells, gated on CD3+γδ+ cells in the spleen. (C) Representative dot plot shows
anti-CD200 and anti-CD73 staining, gated on CD3+γδ+CD25-CD371- cells from WT and Gli21N2-tg spleen, giving the percentage of cells in the region shown.
Scatter plots show the percentage of CD200-CD73- cells, gated on CD3+γδ+CD25-CD371- cells, and the number of CD200-CD73-CD3+γδ+CD25-CD371- cells in
WT and Gli21N2-tg spleen. (D) Representative histograms show anti-Vγ2 staining, gated on CD3+γδ+ cells in the spleen, giving the percentage of cells in the
marker shown. Scatter plots shows the percentage of Vγ2+ cells, gated on CD3+γδ+ cells in the spleen. (E) Scatter plot shows the number of NK1.1+ cells, gated
on CD3+γδ+ cells in the WT and Gli21N2-tg spleen. *p < 0.05; **p < 0.01; ***p < 0.005.
Interestingly, the RNA sequencing analysis identified Klf2 as a
gene that is downregulated in CD27+CD3+γδ+ cells when Hh-
mediated transcription is increased. Klf2 is required for efficient
thymic egress and its deficiency increased the peripheral γδNKT
population, many of which expressed CD4 (49). Consistent with
this, we showed that Hh-mediated transcription also promoted
the γδNKT population, and Cd4was upregulated in the Gli21N2
CD27+CD3+γδ+ RNAseq datasets. In contrast, Shh-mutation
reduced the thymic γδNKT population.
Short-term systemic inhibition of Hh pathway activation
by in vivo pharmacological treatment with a Smo-inhibitor
confirmed that Hh signaling is required for development
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and homeostasis of the γδ T-cell and γδNKT populations
in the thymus, but Smoothened-inhibition also changed the
splenic γδ T-cell subsets over the 2-week treatment period,
decreasing the γδNKT population. This suggests that Hh
signaling continues to actively maintain homeostasis of the
splenic γδ populations, as well as influencing their development
in the thymus. Given that the RNA sequencing analysis
detected changes in the expression of genes that coordinate
lymphocyte migration, it would be interesting in the future to
assess the role of Hh signaling in γδ T-cell tissue localization
and migration.
Hh pathway activation has been shown to limit αβ T-cell
activation and Th1 differentiation, suggesting that Hh protein
secretion by tumors may therefore be a mechanism by which
tumors evade the adaptive immune response (23, 33, 44, 47, 58).
In several studies Hh inhibition has been shown to increase
αβ T-cell mediated immunity to cancer, suggesting that Hh-
inhibitors may be used to enhance the immune response in
immune-therapy (59–62). However, in our present study, we
show that Smo-inhibition reduces the γδ T-cell and γδNKT
populations in spleen and thymus, suggesting that Hh-inhibitors
may not be suitable for use in conjunction with iNKT- or
γδ cell-based immune-therapies, consistent with a previous
report (63).
In summary, we show that Shh and Hh pathway activation
in γδ T-cells are determinants of γδ T-cell development,
maturation and effector subset distribution in the thymus,
influencing multiple stages of development, and that Hh
signaling continues to influence γδ T-cell populations in
the spleen.
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